Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 140 (2) , 459-468.e1
- https://doi.org/10.1053/j.gastro.2010.10.046
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Peginterferon alpha‐2a is associated with higher sustained virological response than peginterferon alfa‐2b in chronic hepatitis CHepatology, 2010
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C InfectionNew England Journal of Medicine, 2009
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2009
- Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patientsHepatology, 2007
- Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis CHepatology, 2007
- Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaJournal of Hepatology, 2005
- Global epidemiology of hepatitis C virus infectionPublished by Elsevier ,2005
- Pharmacokinetics of PeginterferonsSeminars in Liver Disease, 2003
- PegylationClinical Pharmacokinetics, 2001
- Epidemiology of hepatitis CHepatology, 1997